CoChat

Terfenadine-Ketoconazole Interaction: Pharmacokinetic and Electrocardiographic Consequences

Honig, Peter K. · 1993 · JAMA

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To examine prospectively the effects of ketoconazole on the pharmacokinetics and electrocardiographic repolarization pharmacodynamics (corrected QT intervals) of terfenadine in men and women. DESIGN: Prospective cohort study with each subject serving as his or her own control. SETTING: Outpatient cardiology clinic and inpatient telemetry unit for monitoring period. PARTICIPANTS: Six healthy volunteers (four men and two women, aged 24 to 35 years) not taking any prescription or over-the-counter medications. INTERVENTION: After achieving a steady state while taking terfenadine (60 mg every 12 hours for 7 days), daily concomitant oral ketoconazole (200 mg every 12 hours) was added to the subjects' regimen. Pharmacokinetic profiles were obtained while subjects were taking terfenadine alone and after the addition of ketoconazole. Electrocardiograms were obtained at baseline, after 1 week of taking terfenadine alone, and at the time of the second pharmacokinetic profile after the addition of ketoconazole to the regimen. MAIN OUTCOME MEASURES: Terfenadine and its acid metabolite serum concentrations and corrected QT intervals. RESULTS: All subjects had detectable levels of unmetabolized terfenadine after the addition of ketoconazole, which was associated with QT prolongation. Only two of the six subjects could complete the entire course of ketoconazole coadministration. Four subjects received a shortened duration of ketoconazole therapy because of significant electrocardiographic repolarization abnormalities. There was a significant change in the area under the curve of the acid metabolite of terfenadine after the addition of ketoconazole administration. CONCLUSIONS: Ketoconazole alters the metabolism of terfenadine in normal men and women and results in the accumulation of unmetabolized parent drug, which is associated with significant prolongation of the corrected QT interval. This drug combination should be avoided.

Overview

Integrity signals

Registry

Crossref · 10.1001/jama.1993.03500120051025

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 13 references

Cited by

See all 692

Metadata

Authors
Honig, P. K.
Affiliations
Uniformed Services University of the Health Sciences (US)
Corresponding author
Honig, Peter K.
Venue
JAMA
Published
1993-03-24
Volume
269
Issue
12
Pages
1513
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W1972280475
Cited by
664
References
13
Citations by year
2026: 11 · 2025: 4 · 2024: 3 · 2023: 5 · 2022: 4 · 2021: 5 · 2020: 8 · 2019: 5 · 2018: 7 · 2017: 8 · 2016: 19 · 2015: 15 · 2014: 16 · 2013: 13 · 2012: 17
FWCI
44.86
Type
journal article
Language
en
Open access
closed
Locations
  • JAMA (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
terfenadine, ketoconazole, drug interactions, QT prolongation, pharmacokinetics, drug accumulation, antifungal agents, antihistamines
MeSH terms
Adult, Drug Interactions, Electrocardiography, Female, Heart, Humans, Ketoconazole, Male, Prospective Studies, Terfenadine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Terfenadine-Ketoconazole Interaction: Pharmacokinetic and Electrocardiographic Consequences. https://app.cochat.ai/papers/10.1001/jama.1993.03500120051025
The paper
Honig, P. K. (1993). Terfenadine-Ketoconazole Interaction: Pharmacokinetic and Electrocardiographic Consequences. JAMA. https://doi.org/10.1001/jama.1993.03500120051025

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.